Analysts’ Viewpoint
Increase in prevalence of chronic diseases is driving the global autoinjectors market. Conditions such as diabetes, rheumatoid arthritis, multiple sclerosis, and autoimmune diseases require frequent and precise administration of medications. Shift toward self-care and home healthcare has propelled demand for autoinjectors. Surge in incidence of anaphylaxis and severe allergic reactions has fueling demand for autoinjectors, particularly for epinephrine administration. Furthermore, ease of use and accuracy offered by autoinjectors are expected to propel market expansion during the forecast period.
Technological advancements in autoinjector devices offer lucrative opportunities to market players. Manufacturers are continually investing in research & development to improve the functionality, usability, and safety features of autoinjectors.
Autoinjectors are devices designed to deliver a specific dose of medication to patients with ease and precision. These are typically used for self-administration of medications, and offer advantages such as convenience, accuracy, and reduced needlestick injuries.
Autoinjectors have witnessed substantial developments, including integration of electronic features such as dose memory, connectivity, and audio-visual guidance, enhancing patient adherence and monitoring.
Manufacturers are focusing on user-friendly designs, ergonomic features, and improvements in needle safety mechanisms to ensure patient comfort and safety. Moreover, advancements in technology have led to the development of smart autoinjectors capable of wirelessly transmitting data to healthcare providers for monitoring and tracking purposes.
Rise in prevalence of chronic diseases has led to a shift toward self-care and increase in demand for home healthcare. These factors are likely to propel global autoinjectors market size during the forecast periods.
Rise in prevalence of chronic diseases such as diabetes, rheumatoid arthritis, multiple sclerosis, and autoimmune disorders necessitates regular medication administration. This has increased demand for autoinjectors as a convenient and user-friendly method for patients to self-administer their medications, reducing their reliance on healthcare professionals and improving their overall quality of life.
The portable nature and ease of use of autoinjectors make them particularly beneficial for individuals who require frequent injections, allowing them to administer their medication conveniently at home or while on the move.
Prevalence of allergic conditions, including severe allergies and anaphylaxis, has also contributed to the surge in global autoinjectors market demand. Anaphylaxis is a potentially life-threatening allergic reaction that requires immediate administration of epinephrine (adrenaline). Autoinjectors, such as EpiPens, are specifically designed to deliver precise dose of epinephrine during an anaphylactic emergency.
Increase in awareness about anaphylaxis and the importance of timely treatment has induced individuals with allergies and their caregivers to opt for autoinjectors as a crucial tool in managing and responding to allergic reactions.
Advancements in technology are expected to drive the global auto injectable market value by revolutionizing the way injectable medications are administered. These advancements encompass various aspects, including device design, connectivity, usability, and safety features These are aimed at improving patient experience and treatment outcomes.
Device design is one key area of advancement. Manufacturers are continuously innovating to create more user-friendly and intuitive autoinjectors. This involves optimizing the ergonomics of the device, simplifying the injection process, and ensuring accurate dosage delivery. For instance, autoinjectors now feature improved grip designs, ergonomic buttons, and clear visual indicators to facilitate easy and precise administration.
Connectivity is another crucial aspect driving market development. With the integration of digital technologies, autoinjectors can now connect to mobile applications and healthcare platforms, enabling remote monitoring, data collection, and personalized treatment management. Patients can receive reminders, track their injections, and share data with healthcare providers, leading to better treatment adherence and disease management.
Usability enhancements have also played a significant role in propelling the market. Autoinjectors now incorporate features such as audio-visual prompts, systematic instructions, and feedback mechanisms to guide patients through the injection process. These user-friendly features improve patient confidence, especially for individuals who may have limited experience with self-administration.
Safety is a paramount concern, and technological advancements have addressed this by incorporating various safety features in autoinjectors. Needlestick injuries are minimized through mechanisms such as automatic needle retraction or needle shields, reducing the risk of accidental pricks. Some devices also include sensors to detect correct needle placement and prevent injection if not positioned correctly, ensuring precise and safe delivery of medication.
In terms of type, the disposable autoinjectors segment accounted for the largest global autoinjectors market share in 2022. This is ascribed to several key factors. Disposable autoinjectors offer convenience and simplicity to both patients and healthcare providers.
These devices are pre-filled with a specific dose of medication, eliminating the need for manual loading or measurement. Patients can easily self-administer their medication without the hassle of handling needles, drawing up doses, or dealing with vials and syringes. This simplicity makes disposable autoinjectors highly preferred, especially for individuals who may have limited experience or dexterity in medication administration.
Disposable autoinjectors provide enhanced safety features. These are designed to be single-use devices, ensuring sterility and minimizing the risk of contamination or needlestick injuries. Once the medication is administered, the autoinjector is discarded, eliminating the need for needle disposal or cleaning procedure.
Based on route of administration, the subcutaneous segment dominated the global market in 2022. Subcutaneous administration is widely used for the delivery of various medications, including biologics, hormones, and vaccines.
Several therapeutic agents are designed to be administered into the subcutaneous tissue layer, which allows for slower and more controlled absorption into the bloodstream. Autoinjectors specifically designed for subcutaneous injection provide a convenient and effective method for patients to self-administer these medications at home or in clinical settings.
The subcutaneous route offers advantages in terms of bioavailability and pharmacokinetics. Several medications are optimally absorbed and have predictable pharmacokinetic profiles when administered subcutaneously.
Autoinjectors provide consistent and accurate delivery of medication into the subcutaneous tissue, ensuring reliable absorption and maintaining therapeutic drug levels over a prolonged period.
In terms of application, the anaphylaxis segment accounted for the leading share of the global autoinjectors market. Anaphylaxis is a severe and potentially life-threatening allergic reaction that necessitates immediate administration of epinephrine.
Autoinjectors have become the established method for delivering epinephrine during an anaphylactic emergency, making them an indispensable tool in managing this condition.
Prevalence of anaphylaxis is a growing global health concern. Incidence of severe allergic reactions is increasing, with a growing number of individuals being diagnosed with allergies to various triggers such as foods, insect stings, medications, and more. Consequently, demand for autoinjectors to effectively treat anaphylaxis is witnessing significant rise in the market.
Based on end-user, the hospitals & clinics segment dominated the global market in 2022. Autoinjectors are extensively used in hospitals and clinics for various purposes, including the administration of medications for chronic diseases, emergency treatments, and vaccinations. Availability of skilled healthcare professionals in these settings ensures proper training and supervision for patients who require assistance in using autoinjectors.
Hospitals and clinics have well-established infrastructure and resources to support the utilization of autoinjectors. These facilities are equipped with medical professionals, including doctors, nurses, and pharmacists, who play a critical role in prescribing, dispensing, and administering medications via autoinjectors.
Hospitals and clinics have proper storage facilities and inventory management systems to handle the stock of autoinjectors and ensure their availability when needed.
North America benefits from a strong healthcare infrastructure and high prevalence of chronic diseases. Increase in incidence of conditions such as diabetes, rheumatoid arthritis, multiple sclerosis, and autoimmune disorders in the region has led to higher demand for self-administered injectable medications.
Europe has witnessed advancements in technology and innovation in the field of autoinjectors. Manufacturers in the region are continually investing in research and development to enhance product features, usability, and patient experience.
Introduction of user-friendly designs, needle safety mechanisms, and electronic monitoring systems has improved the overall functionality and acceptance of autoinjectors. These technological advancements are propelling the autoinjectors market in Europe.
Government initiatives and policies focused on improving healthcare infrastructure and access to medical technologies have contributed to the growth of the autoinjectors market in Asia Pacific. Governments in countries such as China and India are investing in healthcare reforms, which include the expansion of healthcare facilities and the promotion of self-care practices. Such initiatives create a conducive environment for the adoption of autoinjectors and drive market growth.
The global market is fragmented, with the presence of a number of players. Leading players have adopted strategies such new product development and merger & expansion in order to increase market presence. Ypsomed Holding AG, Novartis AG, BD, Medmix Healthcare, Eli Lilly and Company, Sanofi, Mylan N.V., Amgen, Inc., SHL Medical AG, and Recipharm AB are the prominent players in the market.
The autoinjectors market report profiles key players based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
| Attribute | Detail |
|---|---|
|
Size in 2022 |
US$ 1.0 Bn |
|
Forecast Value in 2031 |
More than US$ 3.8 Bn |
|
CAGR - 2022-2031 |
16.2% |
|
Forecast Period |
2023-2031 |
|
Historical Data Available for |
2017-2021 |
|
Quantitative Units |
US$ Bn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
|
|
Pricing |
|
The global industry was valued at US$ 1.0 Bn in 2022
It is projected to reach more than US$ 3.8 Bn by 2031
The industry is likely to advance at a CAGR of 16.2% from 2023 to 2031
North America is expected to account for largest share from 2022 to 2031
Ypsomed Holding AG, Novartis AG, BD, Medmix Healthcare, Eli Lilly and Company, Sanofi, Mylan N.V., Amgen, Inc., SHL Medical AG, and Recipharm AB are the prominent players in the market
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Autoinjectors Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Autoinjectors Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Technological Advancement
5.2. Disease Incidence and Prevalence
5.3. Overview: Future of Autoinjectors
5.4. Regulatory Analysis
5.5. COVID-19 Impact Analysis
6. Global Autoinjectors Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Type, 2017-2031
6.3.1. Disposable
6.3.2. Reusable
6.4. Market Attractiveness Analysis, by Type
7. Global Autoinjectors Market Analysis and Forecast, by Technology
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Technology, 2017-2031
7.3.1. Handheld
7.3.2. Wearable
7.4. Market Attractiveness Analysis, by Technology
8. Global Autoinjectors Market Analysis and Forecast, by Route of Administration
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Route of Administration, 2017-2031
8.3.1. Subcutaneous
8.3.2. Intramuscular
8.4. Market Attractiveness Analysis, by Route of Administration
9. Global Autoinjectors Market Analysis and Forecast, by Indication
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by Indication, 2017-2031
9.3.1. Multiple Sclerosis
9.3.2. Rheumatoid Arthritis
9.3.3. Diabetes
9.3.4. Anaphylaxsis
9.3.5. Others
9.4. Market Attractiveness Analysis, by Indication
10. Global Autoinjectors Market Analysis and Forecast, by End-user
10.1. Introduction & Definition
10.2. Key Findings / Developments
10.3. Market Value Forecast, by End-user, 2017-2031
10.3.1. Homecare Settings
10.3.2. Hospitals & Clinics
10.4. Market Attractiveness Analysis, by End-user
11. Global Autoinjectors Market Analysis and Forecast, by Region
11.1. Key Findings
11.2. Market Value Forecast, by Region
11.2.1. North America
11.2.2. Europe
11.2.3. Asia Pacific
11.2.4. Latin America
11.2.5. Middle East & Africa
11.3. Market Attractiveness Analysis, by Region
12. North America Autoinjectors Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Type, 2017-2031
12.2.1. Disposable
12.2.2. Reusable
12.3. Market Value Forecast, by Technology, 2017-2031
12.3.1. Handheld
12.3.2. Wearable
12.4. Market Value Forecast, by Route of Administration, 2017-2031
12.4.1. Subcutaneous
12.4.2. Intramuscular
12.5. Market Value Forecast, by Indication, 2017-2031
12.5.1. Multiple Sclerosis
12.5.2. Rheumatoid Arthritis
12.5.3. Diabetes
12.5.4. Anaphylaxsis
12.5.5. Others
12.6. Market Value Forecast, by End-user, 2017-2031
12.6.1. Homecare Settings
12.6.2. Hospitals & Clinics
12.7. Market Value Forecast, by Country, 2017-2031
12.7.1. U.S.
12.7.2. Canada
12.8. Market Attractiveness Analysis
12.8.1. By Type
12.8.2. By Technology
12.8.3. By Route of Administration
12.8.4. By Indication
12.8.5. By End-user
12.8.6. By Country
13. Europe Autoinjectors Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Type, 2017-2031
13.2.1. Disposable
13.2.2. Reusable
13.3. Market Value Forecast, by Technology, 2017-2031
13.3.1. Handheld
13.3.2. Wearable
13.4. Market Value Forecast, by Route of Administration, 2017-2031
13.4.1. Subcutaneous
13.4.2. Intramuscular
13.5. Market Value Forecast, by Indication, 2017-2031
13.5.1. Multiple Sclerosis
13.5.2. Rheumatoid Arthritis
13.5.3. Diabetes
13.5.4. Anaphylaxsis
13.5.5. Others
13.6. Market Value Forecast, by End-user, 2017-2031
13.6.1. Homecare Settings
13.6.2. Hospitals & Clinics
13.7. Market Value Forecast, by Country/Sub-region, 2017-2031
13.7.1. Germany
13.7.2. U.K.
13.7.3. France
13.7.4. Italy
13.7.5. Spain
13.7.6. Rest of Europe
13.8. Market Attractiveness Analysis
13.8.1. By Type
13.8.2. By Technology
13.8.3. By Route of Administration
13.8.4. By Indication
13.8.5. By End-user
13.8.6. By Country/Sub-region
14. Asia Pacific Autoinjectors Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Type, 2017-2031
14.2.1. Disposable
14.2.2. Reusable
14.3. Market Value Forecast, by Technology, 2017-2031
14.3.1. Handheld
14.3.2. Wearable
14.4. Market Value Forecast, by Route of Administration, 2017-2031
14.4.1. Subcutaneous
14.4.2. Intramuscular
14.5. Market Value Forecast, by Indication, 2017-2031
14.5.1. Multiple Sclerosis
14.5.2. Rheumatoid Arthritis
14.5.3. Diabetes
14.5.4. Anaphylaxsis
14.5.5. Others
14.6. Market Value Forecast, by End-user, 2017-2031
14.6.1. Homecare Settings
14.6.2. Hospitals & Clinics
14.7. Market Value Forecast, by Country/Sub-region, 2017-2031
14.7.1. China
14.7.2. Japan
14.7.3. India
14.7.4. Australia & New Zealand
14.7.5. Rest of Asia Pacific
14.8. Market Attractiveness Analysis
14.8.1. By Type
14.8.2. By Route of Administration
14.8.3. By Technology
14.8.4. By Indication
14.8.5. By End-user
14.8.6. By Country/Sub-region
15. Latin America Autoinjectors Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Type, 2017-2031
15.2.1. Disposable
15.2.2. Reusable
15.3. Market Value Forecast, by Technology, 2017-2031
15.3.1. Handheld
15.3.2. Wearable
15.4. Market Value Forecast, by Route of Administration, 2017-2031
15.4.1. Subcutaneous
15.4.2. Intramuscular
15.5. Market Value Forecast, by Indication, 2017-2031
15.5.1. Multiple Sclerosis
15.5.2. Rheumatoid Arthritis
15.5.3. Diabetes
15.5.4. Anaphylaxsis
15.5.5. Others
15.6. Market Value Forecast, by End-user, 2017-2031
15.6.1. Homecare Settings
15.6.2. Hospitals & Clinics
15.7. Market Value Forecast, by Country/Sub-region, 2017-2031
15.7.1. Brazil
15.7.2. Mexico
15.7.3. Rest of Latin America
15.8. Market Attractiveness Analysis
15.8.1. By Type
15.8.2. By Technology
15.8.3. By Route of Administration
15.8.4. By Indication
15.8.5. By End-user
15.8.6. By Country/Sub-region
16. Middle East & Africa Autoinjectors Market Analysis and Forecast
16.1. Introduction
16.1.1. Key Findings
16.2. Market Value Forecast, by Type, 2017-2031
16.2.1. Disposable
16.2.2. Reusable
16.3. Market Value Forecast, by Technology, 2017-2031
16.3.1. Handheld
16.3.2. Wearable
16.4. Market Value Forecast, by Route of Administration, 2017-2031
16.4.1. Subcutaneous
16.4.2. Intramuscular
16.5. Market Value Forecast, by Indication, 2017-2031
16.5.1. Multiple Sclerosis
16.5.2. Rheumatoid Arthritis
16.5.3. Diabetes
16.5.4. Anaphylaxsis
16.5.5. Others
16.6. Market Value Forecast, by End-user, 2017-2031
16.6.1. Homecare Settings
16.6.2. Hospitals & Clinics
16.7. Market Value Forecast, by Country/Sub-region, 2017-2031
16.7.1. GCC Countries
16.7.2. South Africa
16.7.3. Rest of Middle East & Africa
16.8. Market Attractiveness Analysis
16.8.1. By Type
16.8.2. By Technology
16.8.3. By Route of Administration
16.8.4. By Indication
16.8.5. By End-user
16.8.6. By Country/Sub-region
17. Competition Landscape
17.1. Market Player - Competition Matrix (By Tier and Size of companies)
17.2. Market Share Analysis By Company (2022)
17.3. Company Profiles
17.3.1. Ypsomed Holding AG
17.3.1.1. Company Overview
17.3.1.2. Financial Overview
17.3.1.3. Product Portfolio
17.3.1.4. Business Strategies
17.3.1.5. Recent Developments
17.3.2. Novartis AG
17.3.2.1. Company Overview
17.3.2.2. Financial Overview
17.3.2.3. Product Portfolio
17.3.2.4. Business Strategies
17.3.2.4. Recent Developments
17.3.3. BD
17.3.3.1. Company Overview
17.3.3.2. Financial Overview
17.3.3.3. Product Portfolio
17.3.3.4. Business Strategies
17.3.3.5. Recent Developments
17.3.4. Medmix Healthcare
17.3.4.1. Company Overview
17.3.4.2. Financial Overview
17.3.4.3. Product Portfolio
17.3.4.4. Business Strategies
17.3.4.5. Recent Developments
17.3.5. Eli Lilly and Company
17.3.5.1. Company Overview
17.3.5.2. Financial Overview
17.3.5.3. Product Portfolio
17.3.5.4. Business Strategies
17.3.5.5. Recent Developments
17.3.6. Sanofi
17.3.6.1. Company Overview
17.3.6.2. Financial Overview
17.3.6.3. Product Portfolio
17.3.6.4. Business Strategies
17.3.6.5. Recent Developments
17.3.7. Mylan N.V.
17.3.7.1. Company Overview
17.3.7.2. Financial Overview
17.3.7.3. Product Portfolio
17.3.7.4. Business Strategies
17.3.7.5. Recent Developments
17.3.8. Amgen Inc.
17.3.8.1. Company Overview
17.3.8.2. Financial Overview
17.3.8.3. Product Portfolio
17.3.8.4. Business Strategies
17.3.8.5. Recent Developments
17.3.9. SHL Medical AG
17.3.9.1. Company Overview
17.3.9.2. Financial Overview
17.3.9.3. Product Portfolio
17.3.9.4. Business Strategies
17.3.9.5. Recent Developments
17.3.10. Recipharm AB
17.3.10.1. Company Overview
17.3.10.2. Financial Overview
17.3.10.3. Product Portfolio
17.3.10.4. Business Strategies
17.3.10.5. Recent Developments
List of Tables
Table 01: Global Autoinjectors Market Size (US$ Mn) Forecast, by Type, 2017-2031
Table 02: Global Autoinjectors Market Size (US$ Mn) Forecast, by Technology, 2017-2031
Table 03: Global Autoinjectors Market Size (US$ Mn) Forecast, by Route of Administration, 2017-2031
Table 04: Global Autoinjectors Market Size (US$ Mn) Forecast, by Indication, 2017-2031
Table 05: Global Autoinjectors Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 06: Global Autoinjectors Market Value (US$ Mn) Forecast, by Region, 2017-2031
Table 07: North America Autoinjectors Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 08: North America Autoinjectors Market Size (US$ Mn) Forecast, by Type, 2017-2031
Table 09: North America Autoinjectors Market (US$ Mn) Forecast, by Technology, 2017-2031
Table 10: North America Autoinjectors Market Size (US$ Mn) Forecast, by Route of Administration, 2017-2031
Table 11: North America Autoinjectors Market Size (US$ Mn) Forecast, by Indication, 2017-2031
Table 12: North America Autoinjectors Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 13: Europe Autoinjectors Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 14: Europe Autoinjectors Market Size (US$ Mn) Forecast, by Type, 2017-2031
Table 15: Europe Autoinjectors Market Size (US$ Mn) Forecast, by Technology, 2017-2031
Table 16: Europe Autoinjectors Market Size (US$ Mn) Forecast, by Route of Administration, 2017-2031
Table 17: Europe Autoinjectors Market Size (US$ Mn) Forecast, by Indication, 2017-2031
Table 18: Europe Autoinjectors Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 19: Asia Pacific Autoinjectors Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 20: Asia Pacific Autoinjectors Market Size (US$ Mn) Forecast, by Type, 2017-2031
Table 21: Asia Pacific Autoinjectors Market Size (US$ Mn) Forecast, by Technology, 2017-2031
Table 22: Asia Pacific Autoinjectors Market Size (US$ Mn) Forecast, by Route of Administration, 2017-2031
Table 23: Asia Pacific Autoinjectors Market Size (US$ Mn) Forecast, by Indication, 2017-2031
Table 24: Asia Pacific Autoinjectors Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 25: Latin America Autoinjectors Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 26: Latin America Autoinjectors Market Size (US$ Mn) Forecast, by Type, 2017-2031
Table 27: Latin America Autoinjectors Market Size (US$ Mn) Forecast, by Technology 2017-2031
Table 28: Latin America Autoinjectors Market Size (US$ Mn) Forecast, by Route of Administration, 2017-2031
Table 29: Latin America Autoinjectors Market Size (US$ Mn) Forecast, by Indication, 2017-2031
Table 30: Latin America Autoinjectors Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 31: Middle East and Africa Autoinjectors Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 32: Middle East and Africa Autoinjectors Market Size (US$ Mn) Forecast, by Type, 2017-2031
Table 33: Middle East and Africa Autoinjectors Market Size (US$ Mn) Forecast, by Technology, 2017-2031
Table 34: Middle East and Africa Autoinjectors Market Size (US$ Mn) Forecast, by Route of Administration, 2017-2031
Table 35: Middle East and Africa Autoinjectors Market Size (US$ Mn) Forecast, by Indication, 2017-2031
Table 36: Middle East and Africa Autoinjectors Market Size (US$ Mn) Forecast, by End-user, 2017-2031
List of Figures
Figure 01: Global Autoinjectors Market Value (US$ Mn) Forecast, 2017-2031
Figure 02: Global Autoinjectors Market Value Share, by Type, 2022
Figure 03: Global Autoinjectors Market Value Share, by Technology, 2022
Figure 04: Global Autoinjectors Market Value Share, by Indication, 2022
Figure 05: Global Autoinjectors Market Value Share, by Route of Administration, 2022
Figure 06: Global Autoinjectors Market Value Share, by End-user, 2022
Figure 07: Global Autoinjectors Market Value Share Analysis, by Type, 2022 and 2031
Figure 08: Global Autoinjectors Market Revenue (US$ Mn), by Disposable, 2017-2031
Figure 09: Global Autoinjectors Market Revenue (US$ Mn), by Reusable, 2017-2031
Figure 10: Global Autoinjectors Market Attractiveness Analysis, by Type, 2023-2031
Figure 11: Global Autoinjectors Market Value Share Analysis, by Technology, 2022 and 2031
Figure 12: Global Autoinjectors Market Revenue (US$ Mn), by Handheld, 2017-2031
Figure 13: Global Autoinjectors Market Revenue (US$ Mn), by Wearable, 2017-2031
Figure 14: Global Autoinjectors Market Attractiveness Analysis, by Technology, 2023-2031
Figure 15: Global Autoinjectors Market Value Share Analysis, by Route of Administration, 2022 and 2031
Figure 16: Global Autoinjectors Market Revenue (US$ Mn), by Subcutaneous, 2017-2031
Figure 17: Global Autoinjectors Market Revenue (US$ Mn), by Intramuscular, 2017-2031
Figure 18: Global Autoinjectors Market Attractiveness Analysis, by Route of Administration, 2023-2031
Figure 19: Global Autoinjectors Market Value Share Analysis, by Indication, 2022 and 2031
Figure 20: Global Autoinjectors Market Revenue (US$ Mn), by Multiple Sclerosis, 2017-2031
Figure 21: Global Autoinjectors Market Revenue (US$ Mn), by Rheumatoid Arthritis, 2017-2031
Figure 22: Global Autoinjectors Market Revenue (US$ Mn), by Diabetes, 2017-2031
Figure 23: Global Autoinjectors Market Revenue (US$ Mn), by Anaphylaxsis, 2017-2031
Figure 24: Global Autoinjectors Market Attractiveness Analysis, by Indication, 2023-2031
Figure 25: Global Autoinjectors Market Value Share Analysis, by End-user, 2022 and 2031
Figure 26: Global Autoinjectors Market Value Share Analysis, by Homecare Settings, 2022 and 2031
Figure 27: Global Autoinjectors Market Value Share Analysis, by Hospitals & Clinics, 2022 and 2031
Figure 28: Global Autoinjectors Market Attractiveness Analysis, by End-user, 2023-2031
Figure 29: North America Autoinjectors Market Value Share Analysis, by Country, 2022 and 2031
Figure 30: North America Autoinjectors Market Attractiveness Analysis, by Country, 2023-2031
Figure 31: North America Autoinjectors Market Value Share Analysis, by Type, 2022 and 2031
Figure 32: North America Autoinjectors Market Attractiveness Analysis, by Type, 2023-2031
Figure 33: North America Autoinjectors Market Value Share Analysis, by Technology, 2022 and 2031
Figure 34: North America Autoinjectors Market Attractiveness Analysis, by Technology, 2023-2031
Figure 35: North America Autoinjectors Market Value Share Analysis, by Route of Administration, 2022 and 2031
Figure 36: North America Autoinjectors Market Attractiveness Analysis, by Route of Administration, 2023-2031
Figure 37: North America Autoinjectors Market Value Share Analysis, by Indication, 2022 and 2031
Figure 38: North America Autoinjectors Market Attractiveness Analysis, by Indication, 2023-2031
Figure 39: North America Autoinjectors Market Value Share Analysis, by End-user, 2022 and 2031
Figure 40: North America Autoinjectors Market Attractiveness Analysis, by End-user, 2023-2031
Figure 41: Europe Autoinjectors Market Value (US$ Mn) Forecast, 2017-2031
Figure 42: Europe Autoinjectors Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 43: Europe Autoinjectors Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 44: Europe Autoinjectors Market Value Share Analysis, by Type, 2022 and 2031
Figure 45: Europe Autoinjectors Market Attractiveness Analysis, by Type, 2023-2031
Figure 46: Europe Autoinjectors Market Value Share Analysis, by Technology, 2022 and 2031
Figure 47: Europe Autoinjectors Market Attractiveness Analysis, by Technology, 2023-2031
Figure 48: Europe Autoinjectors Market Value Share Analysis, by Route of Administration, 2022 and 2031
Figure 49: Europe Autoinjectors Market Attractiveness Analysis, by Route of Administration, 2023-2031
Figure 50: Europe Autoinjectors Market Value Share Analysis, by Indication, 2022 and 2031
Figure 51: Europe Autoinjectors Market Attractiveness Analysis, by Indication, 2023-2031
Figure 52: Europe Autoinjectors Market Value Share Analysis, by End-user, 2022 and 2031
Figure 53: Europe Autoinjectors Market Attractiveness Analysis, by End-user, 2023-2031
Figure 54: Asia Pacific Autoinjectors Market Value (US$ Mn) Forecast, 2017-2031
Figure 55: Asia Pacific Autoinjectors Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 56: Asia Pacific Autoinjectors Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 57: Asia Pacific Autoinjectors Market Value Share Analysis, by Type, 2022 and 2031
Figure 58: Asia Pacific Autoinjectors Market Attractiveness Analysis, by Type, 2023-2031
Figure 59: Asia Pacific Autoinjectors Market Value Share Analysis, by Technology, 2022 and 2031
Figure 60: Asia Pacific Autoinjectors Market Attractiveness Analysis, by Technology, 2023-2031
Figure 61: Asia Pacific Autoinjectors Market Value Share Analysis, by Route of Administration, 2022 and 2031
Figure 62: Asia Pacific Autoinjectors Market Attractiveness Analysis, by Route of Administration, 2023-2031
Figure 63: Asia Pacific Autoinjectors Market Value Share Analysis, by Indication, 2022 and 2031
Figure 64: Asia Pacific Autoinjectors Market Attractiveness Analysis, by Indication, 2023-2031
Figure 65: Asia Pacific Autoinjectors Market Value Share Analysis, by End-user, 2022 and 2031
Figure 66: Asia Pacific Autoinjectors Market Attractiveness Analysis, by End-user, 2023-2031
Figure 67: Latin America Autoinjectors Market Value (US$ Mn) Forecast, 2017-2031
Figure 68: Latin America Autoinjectors Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 69: Latin America Autoinjectors Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 70: Latin America Autoinjectors Market Value Share Analysis, by Type, 2022 and 2031
Figure 71: Latin America Autoinjectors Market Attractiveness Analysis, by Type, 2023-2031
Figure 72: Latin America Autoinjectors Market Value Share Analysis, by Technology, 2022 and 2031
Figure 73: Latin America Autoinjectors Market Attractiveness Analysis, by Technology, 2023-2031
Figure 74: Latin America Autoinjectors Market Value Share Analysis, by Route of Administration, 2022 and 2031
Figure 75: Latin America Autoinjectors Market Attractiveness Analysis, by Route of Administration, 2023-2031
Figure 76: Latin America Autoinjectors Market Value Share Analysis, by Indication, 2022 and 2031
Figure 77: Latin America Autoinjectors Market Attractiveness Analysis, by Indication, 2023-2031
Figure 78: Latin America Autoinjectors Market Value Share Analysis, by End-user, 2022 and 2031
Figure 79: Latin America Autoinjectors Market Attractiveness Analysis, by End-user, 2023-2031
Figure 80: Middle East and Africa Autoinjectors Market Value (US$ Mn) Forecast, 2017-2031
Figure 81: Middle East and Africa Autoinjectors Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 82: Middle East and Africa Autoinjectors Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 83: Middle East and Africa Autoinjectors Market Value Share Analysis, by Type, 2022 and 2031
Figure 84: Middle East and Africa Autoinjectors Market Attractiveness Analysis, by Type, 2023-2031
Figure 85: Middle East and Africa Autoinjectors Market Value Share Analysis, by Technology, 2022 and 2031
Figure 86: Middle East and Africa Autoinjectors Market Attractiveness Analysis, by Technology, 2023-2031
Figure 87: Middle East and Africa Autoinjectors Market Value Share Analysis, by Route of Administration, 2022 and 2031
Figure 88: Middle East and Africa Autoinjectors Market Attractiveness Analysis, by Route of Administration, 2023-2031
Figure 89: Middle East and Africa Autoinjectors Market Value Share Analysis, by Indication, 2022 and 2031
Figure 90: Middle East and Africa Autoinjectors Market Attractiveness Analysis, by Indication, 2023-2031
Figure 91: Middle East and Africa Autoinjectors Market Value Share Analysis, by End-user, 2022 and 2031
Figure 92: Middle East and Africa Autoinjectors Market Attractiveness Analysis, by End-user, 2023-2031
Figure 93: Company Share Analysis, 2022
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Autoinjectors Market
*86 figures and 60 tables includes